-
This is a prospective trial in which the levonorgestrel-releasing IUD was used in 16 patients who had an inherited bleeding disorder including 13 with von Willebrands disease and 2 with factor XI deficiency. No pelvic pathology was identified in any patient.
-
It has been well documented that women diagnosed with low malignant potential (LMP) tumors have an excellent prognosis with few recurrences identified in those undergoing definitive resection.
-
Schizophrenia is a common form of severe mental illness characterized by disordered thoughts processes, hallucinations, delusions, and social withdrawal. The cause has been attributed to many factors, including obstetrical complications, season of birth, maternal stress, prenatal viral exposure, and poor maternal nutrition.
-
There is a strong tendency today to continue to hospitalize patients diagnosed to have arrested preterm labor.
-
Promising New Weight Loss Drug?; Treating Shift-Work Disorder; Another Flu Vaccine Shortage?; FDA Actions
-
-
Fecal occult blood tests (FOBTS) were performed on samples from digital rectal examinations in 2665 average-risk asymptomatic adults. In addition, each patient had 6-sample at-home FOBTs done. Colonoscopy was also completed in each subject.
-
The present study was undertaken to test the hypothesis that high fruit and vegetable consumption reduces the risk of breast cancer. A multinational team of investigators conducted a prospective, observational study of the relationship between fruit and vegetable intake and invasive breast cancer as part of the European Prospective Investigation Into Cancer and Nutrition (EPIC) study.
-
Sepilian and Nagamani from the University of Texas in Galveston reported the results of rosiglitazone treatment in 12 obese women with polycystic ovaries and insulin resistance. These women were very heavy, with an average BMI of 40.4. The fasting insulin levels (an average of 46.0 µU) were clearly in the range of hyperinsulinemia due to an increase in insulin resistance.
-
Neuropsychiatric Symptoms of Dementia, FDA Actions.
